Facebook
Twitter
LinkedIn
Forward
Annual Review of the 2023 San Antonio Breast Cancer Symposium
This program is designed to discuss the content presented at the 2023 San Antonio Breast Cancer Symposium. Topics surrounding experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease will be highlighted.
Target Audience
Physicians, researchers, advanced practice providers, nurses, and other health care professionals who work with individuals with breast cancer.
Learning Objectives
Upon completion of this program, attendees will be able to:
• Apply cutting edge research in medical and surgical breast oncology into clinical practice
• Discuss advancements made in radiation oncology related to breast cancer
• Identify the current initiatives surrounding palliative and supportive care within breast cancer management
• Recall premalignant disease management with breast oncology
• Recognize efforts involved in breast cancer health maintenance, prevention, and survivorship
• Understand the mechanism of action for the most current pharmaceutical advancements
Additional Information
| Attachment | Size |
|---|---|
 2024 SABCR Handout.pdf | 154.6 KB |
Travel
Parking will be available on site and at the participant's own expense.
COURSE DIRECTORS:
Dhaval Mehta, MD
Clinical Assistant Professor of Medicine
University of Pittsburgh School of Medicine
UPMC Hillman Cancer Center, Monroeville, PA
Shannon Puhalla, MD
UPMC Hillman Cancer Center
UPMC Passavant
UPMC Magee-Womens Hospital
Faculty Disclosure:
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All the relevant financial relationships for the individuals listed below have been mitigated:
Carey K. Anders, MD (Grant/Research Support: PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics, ZION, Novartis, Pfizer, Astra Zeneca, Elucida, Caris, Incyclix; Consultant: Genentech, Eisai, IPSEN, Seattle Genetics, Astra Zeneca, Novartis, Immunomedics, Elucida, Athenex, Roche; Royalties: UpToDate, Jones and Bartlett)
Parul Barry, MD, FACRO (Grant/Research Support: ACRO, Consultant: Elsevier Pathways, and Honorarium: ACRO, ASTRO, Onclive, and Varian)
Wendie Berg, MD, PhD (Grant/Research Support: Koios Medical Inc., Consultant: Exai Bio, Inc)
Adam Brufsky, MD, PhD, FACP (Grant/Research Support: Agendia, AstraZeneca; Consultant: AstraZeneca, Pfizer, Novartis, Lilly, Genentech/Roche, SeaGen, Daiichi Sankyo, Merck, Agendia, Sanofi, Puma)
Charles Geyer, MD, FACP (Grant/Research Support: AstraZeneca, Daiichi Sankyo, Exact Sciences, and Genentech/Roche)
Vikram Gorantla (Consultant: AstraZeneca)
Kit Lu, MD (Consultant: AstraZeneca, Daichii Sankyo, Gilead; CE Speakers’ Bureau: Gilead, SeaGen, Daichii Sankyo, AstraZeneca, Stemline, Merck)
Dhaval Mehta, MD (Consultant: AstraZeneca)
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 4.25 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 4.25 AAPA Category I CME
- 4.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 4.25 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 4.25 Attendance
Price
All cancellations must be sent via email to Amy DiMaggio at dimaggioa@upmc.edu Cancellations received before Wednesday, January 17, 2024 will be refunded in full. After Wednesday, January 17, 2024, no refunds will be made.
For more information, contact Amy DiMaggio at dimaggioa@upmc.edu.